STAT3 and ovarian cancer: We provide evidence that post PARPi treatment phosphorylation of STAT3 in germline BRCA ovarian cancer patient biopsies is significantly increased not only in tumor cells but also in tumor-associated diverse immune cells, as well as cancer-associated fibroblasts (CAFs).